chr15-48485418-C-A
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000138.5(FBN1):c.3668G>T(p.Cys1223Phe) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 11/18 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C1223R) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000138.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBN1 | NM_000138.5 | c.3668G>T | p.Cys1223Phe | missense_variant | 30/66 | ENST00000316623.10 | NP_000129.3 | |
FBN1 | NM_001406716.1 | c.3668G>T | p.Cys1223Phe | missense_variant | 29/65 | NP_001393645.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBN1 | ENST00000316623.10 | c.3668G>T | p.Cys1223Phe | missense_variant | 30/66 | 1 | NM_000138.5 | ENSP00000325527 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Feb 23, 2017 | Although the C1223F variant in the FBN1 gene has not been published as a pathogenic variant or reported as a benign polymorphism to our knowledge, variant in the same residue have been reported in association with Marfan syndrome. Comeglio et al. (2007) reported a C122R variant in a one year old patient with severe Marfan syndrome. Similarly, Hewett et al. (1994) reported a C1223Y variant in a patient with Marfan syndrome, and the variant was not found in any unaffected family members or 100 control samples. Genotype analysis of the proband's unaffected siblings indicated that C1223Y was de novo in the proband (Hewett et al., 1994). The C1223F variant was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. C1223F is a non- conservative amino acid substitution resulting in the removal of a Cysteine, which is expected to affect disulfide bonding, at a position that is highly conserved across species. In silico analysis predicts C1223F is damaging to the protein structure/function. In summary, C1223F in the FBN1 gene is interpreted as a likely disease-causing variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at